COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review

COVID-19 Vaccination Response in Patients with Multiple Sclerosis Treated with Ofatumumab in the United States: A Medical Record Review

Abstract Introduction Real-world data are required to provide a greater understanding of the impact of ofatumumab on the ability to mount an effective immune response following the receipt of approved COVID-19 vaccinations. This retrospective real-world analysis aimed to describe the humoral immune...

Full description

Saved in:
Bibliographic Details
Main Authors: Rahul H. Dave, Heidi Crayton, Augusto Miravalle, Ming-Hui Tai, Kerri Wyse, Katherine Houghton, Abby Hitchens, Regina Berkovich
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-10-01
Series:Neurology and Therapy
Subjects:
Coronavirus 2 (SARS-CoV-2)
Medical records
Multiple sclerosis
Ofatumumab
Real-world evidence
Vaccination
Online Access:https://doi.org/10.1007/s40120-024-00671-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s40120-024-00671-0

Similar Items